Synthesis, characterization and in vitro and in vivo investigation of C3F8-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent

Wang,Cui-Wei; Yang,Shi-Ping; Hu,He; Du,Jing; Li,Feng-Hua

doi:10.3892/mmr.2014.2938

Synthesis, characterization and in vitro and in vivo investigation of C3F8-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent

Authors:
- Cui-Wei Wang
- Shi-Ping Yang
- He Hu
- Jing Du
- Feng-Hua Li
View Affiliations

Affiliations: Department of Ultrasound, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China, Department of Chemistry, Shanghai Normal University, Shanghai 200234, P.R. China
Published online on: November 13, 2014 https://doi.org/10.3892/mmr.2014.2938
Pages: 1885-1890

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to prepare perfluoropropane (C3F8)-filled poly(lactic-co-glycolic acid) (PLGA) nanoparticles and investigate the feasibility of using PLGA nanoparticles as an ultrasound contrast agent. The PLGA nanoscale ultrasound contrast agent was prepared using a modified double-emulsion solvent evaporation method. Camphor in the form of a sublimable porogen was added to render the nanoparticles hollow and enable C3F8 gas introduction. Various physicochemical properties of PLGA nanoparticles, including morphology, size and dispersion, were analyzed by electron microscopy and dynamic laser scattering. In vitro ultrasound imaging of C3F8-filled PLGA nanoparticles was also investigated under various imaging conditions. Further in vivo ultrasound imaging was conducted on male rats following intratesticular injection of PLGA nanoparticles. C3F8-filled PLGA nanoparticles with a mean diameter of 152.0±58.08 nm were obtained. Electron microscopy revealed spherical-shaped nanoparticles with smooth surfaces, a capsular morphology and a large hollow within. In vitro ultrasound imaging of hollow PLGA nanoparticles indicated marked signal enhancement. Local intensity of the acoustical signal continued to increase during PLGA-nanoparticle injection into the testicle and the ability of hollow PLGA nanoparticles to enhance ultrasound imaging in vivo was demonstrated. The enhancement image of testicular tissue following injection with C3F8-filled PLGA nanoparticles was sustained for a minimum of five minutes. In conclusion, the hollow C3F8-filled PLGA nanoparticles were demonstrated to have potential for applications as a novel ultrasound contrast agent.

View Figures

View References

1	Lencioni R, Piscaglia F and Bolondi L: Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol. 48:848–857. 2008. View Article : Google Scholar : PubMed/NCBI
2	Nemec U, Nemec SF, Novotny C, Weber M, Czerny C and Krestan CR: Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy. Eur Radiol. 22:1357–1365. 2012. View Article : Google Scholar : PubMed/NCBI
3	Kornmann LM, Reesink KD, Reneman RS and Hoeks AP: Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries. Ultrasound Med Biol. 36:181–191. 2010. View Article : Google Scholar
4	Shive MS and Anderson JM: Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 28:5–24. 1997. View Article : Google Scholar
5	Pisani E, Tsapis N, Paris J, et al: Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. Langmuir. 22:4397–4402. 2006. View Article : Google Scholar : PubMed/NCBI
6	Basude R, Duckworth JW and Wheatley MA: Influence of environmental conditions on a new surfactant-based contrast agent: ST68. Ultrasound Med Biol. 26:621–628. 2000. View Article : Google Scholar : PubMed/NCBI
7	Oeffinger BE and Wheatley MA: Development and characterization of a nano-scale contrast agent. Ultrasonics. 42:343–347. 2004. View Article : Google Scholar : PubMed/NCBI
8	Sun Y, Zheng Y, Ran H, et al: Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation. Biomaterials. 33:5854–5864. 2012. View Article : Google Scholar : PubMed/NCBI
9	Néstor MM, Kei NP, Guadalupe NA, Elisa ME, Adriana GQ and David QG: Preparation and in vitro evaluation of poly(D,L-lactide-co-glycolide) air-filled nanocapsules as a contrast agent for ultrasound imaging. Ultrasonics. 51:839–845. 2011. View Article : Google Scholar : PubMed/NCBI
10	Kohl Y, Kaiser C, Bost W, et al: Preparation and biological evaluation of multifunctional PLGA-nanoparticles designed for photoacoustic imaging. Nanomedicine. 7:228–237. 2011. View Article : Google Scholar
11	Xu JS, Huang J, Qin R, et al: Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. Biomaterials. 31:1716–1722. 2010. View Article : Google Scholar
12	Xu RX, Huang J, Xu JS, et al: Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer. J Biomed Opt. 14:0340202009. View Article : Google Scholar : PubMed/NCBI
13	Sunoqrot S, Bae JW, Jin SE, Pearson MR, Liu Y and Hong S: Kinetically controlled cellular interactions of polymer-polymer and polymer-liposome nanohybrid systems. Bioconjug Chem. 22:466–474. 2011. View Article : Google Scholar : PubMed/NCBI
14	Chu B: Laser Light Scattering: Basic Principles and Practice. 2nd edition. Academic Press; 1991
15	Xu R: Particle Characterization: Light Scattering Methods. Kluwer Academic Publications; 2000
16	Liu J, Levine AL, Mattoon JS, et al: Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol. 51:2179–2189. 2006. View Article : Google Scholar : PubMed/NCBI
17	Liu J, Li J, Rosol TJ, Pan X and Voorhees JL: Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro. Phys Med Biol. 52:4739–4747. 2007. View Article : Google Scholar : PubMed/NCBI
18	Hu H, Zhou H, Du J, et al: Biocompatible hollow silica microsphere as a novel ultrasound contrast agent for in vivo imaging. J Mater Chem. 21:6576–6583. 2011. View Article : Google Scholar
19	Doiron AL, Homan KA, Emelianov S and Brannon-Peppas L: Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharm Res. 26:674–682. 2009. View Article : Google Scholar
20	Kwon S and Wheatley MA: Gas-loaded PLA nanoparticles as ultrasound contrast agents. IFMBE Proceedings. 14:275–278. 2007. View Article : Google Scholar
21	Wheatley MA, Forsberg F, Oum K, et al: Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent. Ultrasonics. 44:360–367. 2006. View Article : Google Scholar : PubMed/NCBI
22	Eisenbrey JR, Burstein OM, Kambhampati R, Forsberg F, Liu JB and Wheatley MA: Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery. J Control Release. 143:38–44. 2010. View Article : Google Scholar : PubMed/NCBI
23	Yuan F, Dellian M, Fukumura D, et al: Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55:3752–3756. 1995.PubMed/NCBI
24	Moore A, Marecos E, Bogdanov A Jr and Weissleder R: Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology. 214:568–574. 2000. View Article : Google Scholar : PubMed/NCBI
25	Zhou S, Liao X, Li X, Deng X and Li H: Poly-D,L-lactide-co-poly (ethylene glycol) microspheres as potential vaccine delivery systems. J Control Release. 86:195–205. 2003. View Article : Google Scholar : PubMed/NCBI
26	Cheng J, Teply BA, Sherifi I, et al: Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 28:869–876. 2007. View Article : Google Scholar